4.14: 影响蛋白质-药物结合的因素：患者相关因素

蛋白质-药物结合是药代动力学的一个关键方面，受一系列患者相关因素的影响，变化很大。年龄、个体差异和病理状况的复杂相互作用显著影响结合动力学和其后续的药理作用。

年龄是蛋白质-药物结合的关键决定因素。新生儿白蛋白含量低，未结合药物（如苯妥英和地西泮）的浓度较高。相比之下，药物结合增加且肾脏清除率较高的婴儿通常需要更高剂量的药物（如地高辛）才能达到治疗效果。

老年人白蛋白含量降低，α_1-酸性糖蛋白水平升高，游离药物浓度会发生变化。这些与年龄相关的变化会影响药物结合，并导致药代动力学和药效学发生细微变化。

药物结合的个体差异通常归因于遗传和环境因素。遗传倾向在决定个体对药物治疗的反应方面起着关键作用，塑造了复杂的蛋白质-药物相互作用格局。

病理状况主要影响蛋白质含量，从而影响蛋白质-药物结合。由衰老、创伤或烧伤引起的低白蛋白血症（血液白蛋白水平异常低）对结合功效构成重大威胁。同样，高脂蛋白血症（血脂水平异常高）会影响亲脂性药物的结合。

控制蛋白质-药物结合的因素对药代动力学和药效学都有深远的影响。血浆蛋白质-药物结合减少最终导致未结合药物浓度增加。这反过来又会放大药物清除率，触发重新分布，并可能加剧治疗或毒性作用。蛋白质-药物结合的微妙平衡成为药物治疗功效和安全性的关键决定因素。

蛋白质-药物结合因许多患者相关因素而异。

由于不同年龄组的蛋白质含量不同，年龄会影响结合。新生儿表现出低白蛋白，提高了苯妥英钠和地西泮等药物的未结合浓度。

充血性心力衰竭的婴儿由于蛋白质结合和肾脏清除率更高，需要更高的地高辛剂量。

白蛋白降低和 α₁-酸糖蛋白水平升高的老年人会改变游离药物浓度。

个体之间药物结合的差异通常与遗传和环境因素有关。

改变蛋白质含量的病理条件会影响蛋白质-药物结合。由衰老、创伤或烧伤引起的低白蛋白血症会严重损害这种结合。由甲状腺功能减退症或阻塞性肝病引起的高脂蛋白血症会影响亲脂性药物的结合。

这些影响蛋白质-药物结合的因素会影响药物的药代动力学和药效学。血浆蛋白-药物结合减少会增加未结合的药物浓度，有利于组织重新分布和清除。浓度增加也加强了其治疗作用或毒性。

• Protein-drug binding - A critical aspect of pharmacokinetics, influenced by various patient-related factors.
• Albumin - A protein that plays a key role in drug binding, varying with age and health conditions.
• Phenytoin - A medication that exhibits heightened concentrations in neonates due to low albumin content.
• Interindividual variations - Differences in drug binding attributed to genetic and environmental factors.
• Hypoalbuminemia - A pathological condition leading to reduced blood albumin levels, affecting protein-drug binding.

• Define Protein-drug binding – Explain what it is (e.g., factor affecting protein binding).
• Contrast Neonates vs Older people – Explain key differences in drug binding due to age (e.g., albumin pharmacodynamics).
• Explore Examples – Describe scenario of drug binding in various health conditions (e.g., Hypoalbuminemia).
• Explain Interindividual variations – Describe how genetic and environmental factors influence drug binding.
• Apply in Context – Discuss the consequences of altered protein-drug binding on pharmacokinetics and pharmacodynamics.

• [Question 1] What is protein-drug binding and how can various factors affect it?
• [Question 2] How does age influence protein-drug binding?
• [Question 3] What role do pathological conditions like Hypoalbuminemia play in protein-drug binding?

• Students – Understand how protein-drug binding impacts pharmacokinetics and pharmacodynamics.
• Educators – Provides a clear framework for teaching about factors influencing protein-drug binding.
• Researchers – Relevance for scientific study on protein-drug interactions and their implications on pharmacodynamics.
• Pharmacology enthusiasts – Offer insights into the intricate landscape of drug binding and its wide-ranging implications.